CHF does not support the proposed rescheduling of all codeine to Schedule 4 at this point in time. We do not think the delegate has given enough consideration to the significant system wide costs of the rescheduling or the loss of access to a range of medications that do have some benefits to consumers.
This edition contains a report of the highlights from our Members and Stakeholders Forum held in August 2015, as well as links to the presentations.
This review of the Guidelines is an opportunity to continuously improve the way PBAC assesses proposals and we see it as an opportunity to give consumers more opportunity for input into the process. If this potential is to be realised then there needs to be adequate resourcing provided to support consumers and consumer organisations to participate.
The current, fragmented set of primary health services with their emphasis on managing ill health rather than promoting health and wellbeing are not meeting the needs of people with chronic conditions. We need to start putting the services together so they actually form a system that has at its heart the consumer.
CHF's Submission to the Primary Health Care Advisory Group Survey on the Discussion Paper: Better Outcomes for People with Chronic and Complex Conditions through Primary Health Care.
The Working Together Guide provides guidance and examples for building collaborative relationships between individuals, health consumer organisations and research-based pharmaceutical companies.
The Working Together Guide was developed by the Consumers Health Forum of Australia and Medicines Australia in 2005 and was first updated in 2008.
CHF's comments on the Review of the implementation of the national reform agenda on organ and tissue donation and transplantation.